Langerhans cell histiocytosis
Last updated 28 May 2021
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
Langerhans cell histiocytosis is a disorder in which excess immune system cells called Langerhans cells build up in the body. Langerhans cells, which help regulate the immune system, are normally found throughout the body, especially in the skin, lymph nodes, spleen, lungs, liver, and bone marrow. In Langerhans cell histiocytosis, excess immature Langerhans cells usually form tumours called granulomas. Many researchers now consider Langerhans cell histiocytosis to be a form of cancer, but this classification remains controversial.
Video picks for Genetic conditionsVideo library
Description
Langerhans cell histiocytosis is a disorder in which excess immune system cells called Langerhans cells build up in the body. Langerhans cells, which help regulate the immune system, are normally found throughout the body, especially in the skin, lymph nodes, spleen, lungs, liver, and bone marrow. In Langerhans cell histiocytosis, excess immature Langerhans cells usually form tumours called granulomas. Many researchers now consider Langerhans cell histiocytosis to be a form of cancer, but this classification remains controversial.
In approximately 80 percent of affected individuals, one or more granulomas develop in the bones, causing pain and swelling. The granulomas, which usually occur in the skull or the long bones of the arms or legs, may cause the bone to fracture.
Granulomas also frequently occur in the skin, appearing as blisters, reddish bumps, or rashes which can be mild to severe. The pituitary gland may also be affected; this gland is located at the base of the brain and produces hormones that control many important body functions. Without hormone supplementation, affected individuals may experience delayed or absent puberty or an inability to have children (infertility). In addition, pituitary gland damage may result in the production of excessive amounts of urine (diabetes insipidus) and dysfunction of another gland called the thyroid. Thyroid dysfunction can affect the rate of chemical reactions in the body (metabolism), body temperature, skin and hair texture, and behaviour.
In 15 to 20 percent of cases, Langerhans cell histiocytosis affects the lungs, liver, or blood-forming (hematopoietic) system; damage to these organs and tissues may be life-threatening. Lung involvement, which appears as swelling of the small airways (bronchioles) and blood vessels of the lungs, results in stiffening of the lung tissue, breathing problems, and increased risk of infection. Hematopoietic involvement, which occurs when the Langerhans cells crowd out blood-forming cells in the bone marrow, leads to a general reduction in the number of blood cells (pancytopenia). Pancytopenia results in fatigue due to low numbers of red blood cells (anaemia), frequent infections due to low numbers of white blood cells (neutropenia), and clotting problems due to low numbers of platelets (thrombocytopenia).
Other signs and symptoms that may occur in Langerhans cell histiocytosis, depending on which organs and tissues have Langerhans cell deposits, include swollen lymph nodes, abdominal pain, yellowing of the skin and whites of the eyes (jaundice), delayed puberty, protruding eyes, dizziness, irritability, and seizures. About 1 in 50 affected individuals experience deterioration of neurological function (neurodegeneration).
Langerhans cell histiocytosis is often diagnosed in childhood, usually between ages 2 and 3, but can appear at any age. Most individuals with adult-onset Langerhans cell histiocytosis are current or past smokers; in about two-thirds of adult-onset cases the disorder affects only the lungs.
The severity of Langerhans cell histiocytosis, and its signs and symptoms, vary widely among affected individuals. Certain presentations or forms of the disorder were formerly considered to be separate diseases. Older names that were sometimes used for forms of Langerhans cell histiocytosis include eosinophilic granuloma, Hand-Schüller-Christian disease, and Letterer-Siwe disease.
In many people with Langerhans cell histiocytosis, the disorder eventually goes away with appropriate treatment. It may even disappear on its own, especially if the disease occurs only in the skin. However, some complications of the condition, such as diabetes insipidus or other effects of tissue and organ damage, may be permanent.
Inheritance patterns
The source lists the following possible inheritance patterns: Pattern unknown. More than one pattern can apply in different cases.
Related genes
Other names
Hashimoto-Pritzger disease
Histiocytosis X
Langerhans cell granulomatosis
LCH
Patient picks for Genetic conditions

Allergies, blood and immune system
Polycythaemia rubra vera
Polycythaemia rubra vera (PRV) is a myeloproliferative disorder, which means the bone marrow makes too many blood cells. It is also sometimes just called polycythaemia (PV). There is an abnormally high number of red blood cells in your blood. You may also have an abnormally high number of platelets and white blood cells.
by Dr Hayley Willacy, FRCGP

Allergies, blood and immune system
Mastocytosis and mast cell disorders
A mast cell is a type of white blood cell. There are several forms of mastocytosis. In one, there are too many mast cells in the body: in another the number of mast cells is normal but they are too active.
by Dr Laurence Knott

Cancer
Stem cell transplant
A stem cell transplant is where blood stem cells (the cells produced by the bone marrow to turn into different types of blood cells) are put back into your body when your bone marrow has been destroyed and cannot make stem cells itself. The bone marrow can be destroyed by diseases such as cancer, chemotherapy or radiotherapy. It is used to increase the chance of a cure or remission if you have a particular type of cancer or blood disorder. It usually involves intense chemotherapy followed by an infusion of stem cells. The treatment requires close nursing and medical care for a number of weeks. Your specialist would advise when the likely benefits of this procedure outweigh the risks.
by Dr Philippa Vincent, MRCGP

Cancer
Women 'not warned' about side effects of treatment to remove precancerous cervical cells
New research suggests that women are not being informed about the potential side effects of treatment for abnormal cells following a cervical smear test.
by Milly Evans

Cancer
What to expect during a LLETZ procedure for abnormal cells
Post 25, regular cervical screening is part of many people's medical routine. Often, cervical cells are completely normal and no further action is taken; you're usually asked to come back for another smear test in three years time. But in others, abnormal cells are detected and further treatment is needed. One such treatment is the LLETZ. But what is it, how does it work, and what are its side effects?
by Emily Reynolds

Heart health and blood vessels
Giant Cell Arteritis
Giant cell arteritis is also known as temporal arteritis. The typical symptoms of giant cell arteritis (temporal arteritis) are headache, tenderness over one or both sides of the forehead, and feeling generally unwell. Other symptoms that may occur include pain in your jaw muscles when chewing, and visual loss. Seek medical attention immediately if you suspect that you have giant cell arteritis. People with giant cell arteritis need urgent treatment with steroids. Prompt treatment aims to prevent serious complications such as severe sight impairment which can occur soon after the disease starts.
by Dr Philippa Vincent, MRCGP
Related patient information and medicines

Patient information leaflet
Acute pancreatitis
Acute pancreatitis is an inflammation of the pancreas that develops quickly. The main symptom is abdominal pain. The enzymes are in an inactive form in the pancreas (otherwise they wou... They are 'activated' in the duodenum to digest food. PatientPicksPlaceholder Groups of special cells called 'islets of Langerhans' are scattered throughout the.

Patient information leaflet
Genetic testing
Genetic testing is a type of medical test that identifies changes in chromosomes, genes or proteins. Genetic tests examine a person's DNA in a variety of ways to assess a person's genetic health. We all have 46 chromosomes in our cells. Genes are short sections of DNA and each chromosome contains hundreds to thousands of genes. Genes contain the.

Patient information leaflet
Spleen pain
This leaflet gives a brief overview of the spleen and its functions. What is the spleen. Haemoglobin is a chemi... It is found within the cells and is also broken down and then recycled. See the separate leaflet called Hereditary Spherocytosis as an example of a condition with abnormal red blood cells Hereditary spherocytosis. It also stores up to.

Patient information leaflet
Coombs test
A Coombs test is a type of blood test. It is named after the person who invented it, Dr Robin Coombs. There are two types of Coombs test. What is a Coombs test. The two types of Coombs test are as follows: The direct Coombs test involves looking directly at red blood cells found in a sample of blood. The direct Coombs test is sometimes called the.

Patient information leaflet
The immune system
A person with a weak immune system might have difficulty fighting off infections. In autoimmune diseases the body is unable to tell what is its own and what is foreign, so it attacks itself. Autoimmune diseases can attack any part of the body - eg, type 1 diabetes (pancreas), multiple sclerosis (brain and nerves), systemic lupus erythematosus.

Patient information leaflet
Primary bone cancer
Primary bone cancer occurs where a cancer originates in a bone. Treatments which may be considered include surgery, chemotherapy and radiotherapy. The hard bone tissue is made... It most commonly affects the pelvis, shoulder blade (scapula), ribs, and the bones of the upper parts of the arms and legs. Other Other rare types of primary bone tumour.
Further reading and references
- Langerhans cell histiocytosis; MedlinePlus, National Library of Medicine.
- Allen CE, Parsons DW. Biological and clinical significance of somatic mutations in Langerhans cell histiocytosis and related histiocytic neoplastic disorders. Hematology Am Soc Hematol Educ Program. 2015;2015:559-64. doi: 10.1182/asheducation-2015.1.559.
- Collin M, Bigley V, McClain KL, Allen CE. Cell(s) of Origin of Langerhans Cell Histiocytosis. Hematol Oncol Clin North Am. 2015 Oct;29(5):825-38. doi: 10.1016/j.hoc.2015.06.003. Epub 2015 Aug 20.
- Egeler RM, Katewa S, Leenen PJ, Beverley P, Collin M, Ginhoux F, Arceci RJ, Rollins BJ; Steering Committee of the Nikolas Symposium. Langerhans cell histiocytosis is a neoplasm and consequently its recurrence is a relapse: In memory of Bob Arceci. Pediatr Blood Cancer. 2016 Oct;63(10):1704-12. doi: 10.1002/pbc.26104. Epub 2016 Jun 17.
- El Demellawy D, Young JL, de Nanassy J, Chernetsova E, Nasr A. Langerhans cell histiocytosis: a comprehensive review. Pathology. 2015 Jun;47(4):294-301. doi: 10.1097/PAT.0000000000000256.
- Grana N. Langerhans cell histiocytosis. Cancer Control. 2014 Oct;21(4):328-34. doi: 10.1177/107327481402100409.
- Harmon CM, Brown N. Langerhans Cell Histiocytosis: A Clinicopathologic Review and Molecular Pathogenetic Update. Arch Pathol Lab Med. 2015 Oct;139(10):1211-4. doi: 10.5858/arpa.2015-0199-RA.
- Monsereenusorn C, Rodriguez-Galindo C. Clinical Characteristics and Treatment of Langerhans Cell Histiocytosis. Hematol Oncol Clin North Am. 2015 Oct;29(5):853-73. doi: 10.1016/j.hoc.2015.06.005. Epub 2015 Aug 18.
- Nelson DS, van Halteren A, Quispel WT, van den Bos C, Bovee JV, Patel B, Badalian-Very G, van Hummelen P, Ducar M, Lin L, MacConaill LE, Egeler RM, Rollins BJ. MAP2K1 and MAP3K1 mutations in Langerhans cell histiocytosis. Genes Chromosomes Cancer. 2015 Jun;54(6):361-8. doi: 10.1002/gcc.22247. Epub 2015 Mar 31.
- Roden AC, Hu X, Kip S, Parrilla Castellar ER, Rumilla KM, Vrana JA, Vassallo R, Ryu JH, Yi ES. BRAF V600E expression in Langerhans cell histiocytosis: clinical and immunohistochemical study on 25 pulmonary and 54 extrapulmonary cases. Am J Surg Pathol. 2014 Apr;38(4):548-51. doi: 10.1097/PAS.0000000000000129.
- Rollins BJ. Genomic Alterations in Langerhans Cell Histiocytosis. Hematol Oncol Clin North Am. 2015 Oct;29(5):839-51. doi: 10.1016/j.hoc.2015.06.004.
- Zinn DJ, Chakraborty R, Allen CE. Langerhans Cell Histiocytosis: Emerging Insights and Clinical Implications. Oncology (Williston Park). 2016 Feb;30(2):122-32, 139.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

